0001209191-20-030893.txt : 20200520
0001209191-20-030893.hdr.sgml : 20200520
20200520163529
ACCESSION NUMBER: 0001209191-20-030893
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200518
FILED AS OF DATE: 20200520
DATE AS OF CHANGE: 20200520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herrmann John A III
CENTRAL INDEX KEY: 0001610928
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 20898592
MAIL ADDRESS:
STREET 1: C/O NOVAVAX, INC.
STREET 2: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-18
0
0001000694
NOVAVAX INC
NVAX
0001610928
Herrmann John A III
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
0
1
0
0
SVP, General Counsel
Common Stock
2020-05-18
4
M
0
7499
25.60
A
7774
D
Common Stock
2020-05-18
4
S
0
7499
49.44
D
275
D
Common Stock
2020-05-18
4
M
0
5462
27.00
A
5737
D
Common Stock
2020-05-18
4
S
0
5462
49.44
D
275
D
Stock Option (Right to buy)
25.60
2020-05-18
4
M
0
7499
0.00
D
2022-03-01
Common Stock
7499
0
D
Stock Option (Right to buy)
27.00
2020-05-18
4
M
0
5462
0.00
D
2026-11-14
Common Stock
5462
787
D
The shares subject to this option grant under the Novavax, Inc. 2005 Stock Incentive Plan, as amended, vested in four equal annual installments on the first four anniversaries of the March 1, 2012 grant date.
Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the November 14, 2016 grant date, and the remaining seventy-five percent (75%) of the shares vested in equal monthly installments over the following three years.
/s/ John A. Herrmann III
2020-05-20